コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 m and exhibited metabolic stability with low intrinsic clearance.
2 ayed improved oral bioavailability and lower intrinsic clearance.
6 d AVI-6451, a potent Mac1 inhibitor with low intrinsic clearance and high oral bioavailability that a
7 e-NH2 resulted in high affinity and improved intrinsic clearance and intestinal epithelial permeabili
9 75 displayed excellent microsomal stability, intrinsic clearance, and hepatic extraction ratios with
10 In this article, we describe an in vitro intrinsic clearance-based approach to the optimization o
11 trinsic clearance to a prediction of in vivo intrinsic clearance by reconciling the enzymatic content
12 bioconcentration factor (BCF), the in vitro intrinsic clearance (CL(IN VITRO,INT)) from rainbow trou
14 These compounds have significantly reduced intrinsic clearance compared to our initial series of py
15 hile increasing polarity in order to improve intrinsic clearance culminated with the discovery of pur
17 ty-purified liver GST and GST-alpha 1-1, the intrinsic clearance for busulfan conjugation was 0.87 an
20 vatives with low cynomolgus monkey and human intrinsic clearance gave 2',6'-dimethyl-3'-pyridyl R-sec
21 ges the common approach of screening for low intrinsic clearance in vitro to target high unbound expo
24 previous study with determination of hepatic intrinsic clearance of (1)(8)F-FDGal (V*(max/K*(m)).
25 bility assay revealed high stability and low intrinsic clearance of 17d (T(1/2) > 145 min and CL(int(
27 val kinetics of galactose, including hepatic intrinsic clearance of galactose (V(max)/K(m)) from meas
29 and 6.2-fold (S457F, P < 0.01), whereas the intrinsic clearance of methotrexate was reduced by 4.2-f
30 tudy, three laboratories determined in vitro intrinsic clearance of six reference compounds (benzo[a]
31 me P450 (CYP) enzymes is responsible for the intrinsic clearance of the majority of therapeutic drugs
33 ytes can be used to reliably obtain in vitro intrinsic clearance of xenobiotics, which provides suppo
34 ed in preclinical models, but the high human intrinsic clearance precluded further development and pr
35 ed in preclinical models, but the high human intrinsic clearance precluded further development and pr
36 etabolism in vitro, scaling-up this in vitro intrinsic clearance to a prediction of in vivo intrinsic
37 tory variability (% CV) in measured in vitro intrinsic clearance values ranged from 4.1 to 30%, while
39 )C-CSar from blood to bile, as quantified by intrinsic clearance, was significantly lower in experime